Negative methacholine challenge tests in subjects who report physician-diagnosed asthma

Clinical and Experimental Allergy

Volumn 41, Issue 1, 2011, Pages 46-51

  McGrath, K W ^a   Fahy, J V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSF Department of Medicine   (United States)

Author keywords

Asthma; Brochoprovocation testing; Diagnosis and assessment

Indexed keywords

METHACHOLINE;

ADULT; ARTICLE; ASTHMA; CHEST TIGHTNESS; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; COUGHING; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PRIORITY JOURNAL; SPIROMETRY; STEROID THERAPY; WHEEZING;

ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHIAL PROVOCATION TESTS; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PHYSICIANS; YOUNG ADULT;

EID: 78650032438     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03627.x     Document Type: Article

References (24)

1. Moorman JE, Rudd RA, Johnson CA et al. National surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ 2007; 56:1-54.
2. Slaughter MC. Not quite asthma: differential diagnosis of dyspnea, cough, and wheezing. Allergy Asthma Proc 2007; 28:271-81.
3. Expert Panel Report 3 (EPR-3): guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120:S94-S138.
4. Celli BR. The importance of spirometry in COPD and asthma: effect on approach to management. Chest 2000; 117:15S-19S.
5. Crapo RO, Casaburi R, Guidelines for methacholine and exercise challenge testing - 1999 et al. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309-29.
6. Aaron SD, Vandemheen KL, Boulet LP et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008; 179:1121-31.
7. Gardner RM, Hankinson JL. Standardization of spirometry - 1987 ATS update (American Thoracic Society). J Occup Med 1988; 30:272-3.
8. Innes AL, Woodruff PG, Ferrando RE et al. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006; 130:1102-8.
9. LindenSmith J, Morrison D, Deveau C, Hernandez P. Overdiagnosis of asthma in the community. Can Respir J 2004; 11:111-6.
10. Haby MM, Anderson SD, Peat JK, Mellis CM, Toelle BG, Woolcock AJ. An exercise challenge protocol for epidemiological studies of asthma in children: comparison with histamine challenge. Eur Respir J 1994; 7:43-9.
11. Backer V, Ulrik CS. Bronchial responsiveness to exercise in a random sample of 494 children and adolescents from Copenhagen. Clin Exp Allergy 1992; 22:741-7.
12. Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res 2009; 10:4.
13. Holzer K, Anderson SD, Chan HK, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003; 167:534-7.
14. Prieto L, Lopez V, Llusar R, Rojas R, Marin J. Differences in the response to methacholine between the tidal breathing and dosimeter methods: influence of the dose of bronchoconstrictor agent delivered to the mouth. Chest 2008; 134:699-703.
15. Cockcroft DW, Davis BE. The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result. J Allergy Clin Immunol 2006; 117:1244-8.
16. Ulrik CS. Factors associated with increased bronchial responsiveness in adolescents and young adults: the importance of adjustment for prechallenge FEV1. J Allergy Clin Immunol 1996; 97:761-7.
17. Green M, Mead J, Turner JM. Variability of maximum expiratory flow-volume curves. J Appl Physiol 1974; 37:67-74.
18. Litonjua AA, Sparrow D, Weiss ST. The FEF25-75/FVC ratio is associated with methacholine airway responsiveness. The normative aging study. Am J Respir Crit Care Med 1999; 159:1574-9.
19. Parker AL, Abu-Hijleh M, McCool FD. Ratio between forced expiratory flow between 25% and 75% of vital capacity and FVC is a determinant of airway reactivity and sensitivity to methacholine. Chest 2003; 124:63-9.
20. Tager IB, Weiss ST, Munoz A, Welty C, Speizer FE. Determinants of response to eucapneic hyperventilation with cold air in a population-based study. Am Rev Respir Dis 1986; 134:502-8.
21. Lucas AE, Smeenk FW, Smeele IJ, Van Schayck CP. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 2008; 25:86-91.
22. Van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J Suppl 2003; 39:16s-22s.
23. Weidinger P, Nilsson JL, Lindblad U. Adherence to diagnostic guidelines and quality indicators in asthma and COPD in Swedish primary care. Pharmacoepidemiol Drug Saf 2009; 18:393-400.
24. Van Essen-Zandvliet EE, Hop WC, De Jong H, Ferwerda A, Kerrebijn KF. Minor acute effect of an inhaled corticosteroid (budesonide) on bronchial hyperresponsiveness to methacholine in children with asthma. Eur Respir J 1993; 6:383-6.